Home Abstracts » Abstract Topics


Abstracts on research from all areas of the molecular and cellular life sciences are welcome at FEBS 2016. However, authors must select one category out of the topics below that best describes the content of their abstract. Categories will be used for reviewing and indexing purposes.

  • Aging
  • Autophagy: Regulation mechanisms
  • Biochemical mechanisms in tolerance and autoimmunity
  • Cardiac regeneration: Programming human heart cells
  • Cell cycle and circadian clocks
  • Chemical and biochemical aspects of oxidative stress
  • Computational biology
  • Developmental biology
  • Developments in biomaterials and tissue engineering
  • DNA repair and cancer
  • DNA replication and recombination: Novel aspects
  • Education, Training, and Career Planning in Molecular Life Sciences
  • Epigenetics and cancer
  • Extracellular matrix and metalloproteinases
  • Functional genomics and proteomics
  • Host-pathogen interactions
  • Human microbiome (microbiota)
  • Intracellular organization
  • Mechanism of neurodegenerative diseases
  • Mechanisms and regulation of protein translocation
  • Mechanisms of pro-inflammatory diseases
  • MicroRNAs and noncoding RNAs
  • Miscellaneous
  • Molecular mechanisms of inflammation
  • New optical methods for studying neuronal structure and function
  • Novel signaling pathways controlling cardiac function
  • Nuclear architecture
  • Personalized medicine
  • Plant biochemistry and molecular biology
  • Proteins in action
  • RNA biology, biogenesis and processing
  • Single molecule techniques - Applications in biology
  • Stem cells and cancer
  • Structural biology: Membrane complexes and supercomplexes
  • Systems biology

Journals from FEBS: FEBS has twin commitments to high-quality publications and the promotion of molecular biosciences. As a charitable academic organization, FEBS uses income from the journals to fund its diverse activities, including support for the FEBS Congress.
IFCC: IFCC auspices have been given to this event.